Annotation Detail for LPA

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| Metabolism of lipids and lipoproteins |
| Pathway ID | Pathway Name |
|---|
| 200108 | amb2 Integrin signaling |
| Pathway ID | Pathway Name |
|---|
| P00050 | Plasminogen activating cascade |
| Pathway ID | Pathway Name |
|---|
| 500798 | LDL-mediated lipid transport |
| Desease ID | Desease Name |
|---|
| 1856 | Obesity |
| 1904 | Diabetes mellitus |
| 2007 | Liver tumor |
| 2022 | Liver cancer |
| 2107 | Proteinuria |
| 2236 | Cardiovascular disease |
| Desease Name |
|---|
| plasma Lp (a) levels |
| CARDIOVASCULAR |
| protein quantitative trait loci |
| Coronary Artery Disease |
| myocardial infarct |
| Alzheimer's disease |
| atherosclerosis, coronary lipoprotein |
| NEUROLOGICAL |
| METABOLIC |
| Desease Name |
|---|
| Protein quantitative trait loci |
| Plasma Lp (a) levels |
| Desease Name |
|---|
| LPA deficiency, congenital |
| Coronary artery disease, susceptibility to |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [LPA protein modified form results in decreased expression of PLAT protein] | decreases expression|decreases reaction | 10856522
|
| D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [LPA protein modified form results in increased expression of PLAT protein] | decreases reaction|increases expression | 10856522
|
| D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [LPA protein results in decreased expression of SERPINE1 protein] | decreases expression|decreases reaction | 10856522
|
| D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [LPA protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 10856522
|
| D002246 |
Carbon Disulfide |
Carbon Disulfide results in increased expression of LPA protein | increases expression | 12712689
|
| C004479 |
pimagedine |
pimagedine inhibits the reaction [LPA protein modified form results in decreased expression of PLAT protein] | decreases expression|decreases reaction | 10856522
|
| C004479 |
pimagedine |
pimagedine inhibits the reaction [LPA protein modified form results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 10856522
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of LPA mRNA | decreases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D050197 |
Atherosclerosis |
marker/mechanism |
|
| |
| MESH:D050197 |
Atherosclerosis |
|
Carbon Disulfide |
5.13 | 10658303 10367350 |
| MESH:D009202 |
Cardiomyopathies |
|
pimagedine |
5.11 | 16612575 |
| MESH:D002386 |
Cataract |
|
pimagedine |
4.98 | 17936468 15003327 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.31 | 15894690 |
| MESH:D003324 |
Coronary Artery Disease |
marker/mechanism |
|
| 20435227 21378990 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.15 | 16285004 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.36 | 15131321 |
| MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.90 | 17604070 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.52 | 14714311 |
| MESH:D007410 |
Intestinal Diseases |
|
pimagedine |
6.01 | 11713966 |
| MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
3.46 | 18177683 |
| MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
2.87 | 11246140 18597497 19359593 19925653 16337739 15390079 11696405 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.52 | 14737004 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
3.98 | 1500032 |
| MESH:D009422 |
Nervous System Diseases |
|
Carbon Disulfide |
6.10 | 10669001 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Carbon Disulfide |
5.56 | 15315294 |
| MESH:D020734 |
Parkinsonian Disorders |
|
Carbon Disulfide |
6.03 | 15019297 |
| MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
5.79 | 11893704 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.33 | 18760546 |
| MESH:D013276 |
Stomach Ulcer |
|
pimagedine |
5.13 | 18209962 |
| MESH:D013927 |
Thrombosis |
marker/mechanism |
|
| |
| Pathway ID |
Pathway Name |
|---|
| REACT:22258 |
Metabolism of lipids and lipoproteins |
| KEGG:04080 |
Neuroactive ligand-receptor interaction |
| KEGG:04810 |
Regulation of actin cytoskeleton |
PharmGKB Accession:PA30432
| Releated disease ID |
Related disease Name |
| PA443797 | Coronary Disease |
| Drugbank ID |
Action |
Drug Name |
Description |
|---|
| DB00513 |
other |
Aminocaproic Acid |
Antifibrinolytic Agents |